Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04704700
Other study ID # 2020-A02443-36
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date July 2024

Study information

Verified date April 2023
Source Clinique Bizet
Contact bouchra benkessou
Phone 0033143967823
Email b.benkessou@clinique-bltparis.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluate the re-rupture rate 12 months following the intervention in a group with and a group without a spacer


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date July 2024
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 75 Years
Eligibility Inclusion Criteria: - First intention of the rotator cuff - Repairable supraspinatus and infraspinatus type 2 rupture (according to the PATTE classification, tendon retraction at the top of the humeral head) - No surgical history - Patient who has given his participation agreement to participate in the observational study after information by the surgeon, - Patient living in France and having the capacity to answer alone to the survey. - Subject affiliated to a social security scheme - Lack of participation in another clinical study Exclusion Criteria: - Major subject protected by law, under curatorship or tutorship - Known allergy to Inspace medical device materials (PLA and -?-caprolactone copolymer) - Osteoporosis - Damaged cartilage - Isolated rupture of the suprascapularis - Glenohumeral instability - Pseudo-paralytic shoulder- Infection - Necrosis - Major joint trauma - Pregnant or breastfeeding women

Study Design


Related Conditions & MeSH terms


Intervention

Device:
repair of a cuff tear
Group (Treatment): Arthroscopic Implantation of the System InSpace on a repaired rotator cuff tendon
repair of a cuff tear
Group (Control): standard Arthroscopic repair of the cuff rotator

Locations

Country Name City State
France Clinique Bizet Paris

Sponsors (1)

Lead Sponsor Collaborator
Clinique Bizet

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the re-rupture rate with radiological imaging 12 months
Secondary Evaluate mobility the Constant score up to 12 months
Secondary Assess shoulder pain VISUAL ANALOGIC SCALE up to 12 months
Secondary the quality of life assessed Simple Shoulder Test, Subjective Shoulder Value and American Shoulder and Elbow Surgeons Shoulder Score up to 12 months
Secondary resumption of work Physicians Global Assessment for resumption of work up to 12 months